Purpose: In this study, the authors sought to determine the prevalence of stuttering in African American (AA) 2- to 5-year-olds as compared with same-age European Americans (EAs).
Method: A total of 3,164 children participated: 2,223 AAs and 941 EAs. Data were collected using a 3-pronged approach that included investigators' individual interactions with each child, teacher identification, and parent identification of stuttering.
Results: No statistically significant difference for stuttering was found between AA and EA children. Using the investigator and teacher method of identification, the prevalence of stuttering was 2.52% for the entire sample. For both racial groups, boys exhibited a higher prevalence of stuttering than girls. Of the 3 predictors (age, race, sex) of stuttering, only sex was a significant predictor.
Conclusions: AA 2- to 5-year-olds are not overrepresented in the stuttering population for this age group. When data are combined for both racial groups, the prevalence of stuttering is 2.52%. More boys than girls stuttered in this sample of preschoolers.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1044/1092-4388(2008/07-0057) | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development and evaluation of a combined fluency rules program (FRP) with parent-child interaction training for preschool children who stutter: A randomized controlled trial.
Int J Pediatr Otorhinolaryngol
December 2024
Department of Speech Therapy, Pediatric Neurorehabilitation Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Introduction: This study aimed to develop and evaluate the effectiveness of a combined Fluency Rules Program (FRP) with parent-child interaction training for preschool children with stuttering.
Methods: A randomized controlled trial was conducted with 49 preschool children who stuttered. Participants were randomly assigned to either the experimental group, which received the combined FRP with parent-child interaction training, or the control group, which received only the FRP.
Adult stuttering prevalence I: Systematic review and identification of stuttering in large populations.
J Fluency Disord
October 2024
Manchester Centre for Audiology & Deafness (ManCAD), University of Manchester, Oxford Road, Manchester M13 9PL, UK.
Article Synopsis
- The review aims to evaluate the methods for identifying stuttering in large populations and provide accurate estimates of adult stuttering prevalence.
- Data from 15 studies were analyzed for quality, with three meeting the inclusion criteria, revealing adult stuttering prevalence rates ranging from 0.21% to 0.67%.
- The findings highlight a paradox where low prevalence necessitates very high specificity in measurements, suggesting that covert stuttering might be underreported, although refining estimates is unlikely to surpass a 1% prevalence rate.
Adult stuttering prevalence II: Recalculation, subgrouping and estimate of stuttering community engagement.
J Fluency Disord
September 2024
Manchester Centre for Audiology & Deafness (ManCAD), University of Manchester, Oxford Road, Manchester M13 9PL, UK.
Purpose: Epidemiological research of stuttering has frequently focused on children, with a relative paucity of population level data specific to adults. Prevalence data for adults are reassessed here, including a breakdown of whether stuttering is overt or covert, and whether onset was in childhood or adulthood. The engagement of adults who stutter with stuttering communities is also estimated.
View Article and Find Full Text PDFImpaired liver function: effect on paclitaxel toxicity, dose modifications and overall survival.
BMC Cancer
December 2024
Department of Clinical Pharmacy, University Medical Center Utrecht, PO Box 85500, Utrecht, 3508 GA, The Netherlands.
Article Synopsis
- The study examines how impaired liver function affects the toxicity of the anticancer drug paclitaxel, specifically focusing on hematological complications, dose modifications, and overall survival rates in cancer patients.
- It analyzes data from 569 patients treated at the University Medical Centre Utrecht between 2011 and 2022, comparing those with normal and impaired liver function based on specific medical criteria.
- Results show that patients with liver impairment experienced significantly higher risks of severe neutropenia and leukopenia, required more dose modifications, and had poorer overall survival in cases of inoperable esophageal and advanced ovarian cancers.
Vascular risk factors are associated with grey matter atrophy in secondary progressive multiple sclerosis.
Eur J Neurol
January 2025
Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
Background: Comorbidities including vascular risk factors can be associated with whole and regional brain atrophy in multiple sclerosis (MS). This has been examined in mixed MS cohorts in prospective or observational studies; however, the association between vascular comorbidities (VCM) in secondary progressive MS (SPMS) and brain atrophy has been less well studied. The aim was to investigate the cross-sectional and longitudinal association between VCM, comorbidity burden and brain atrophy in SPMS.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!